5 Best Cheapest Stocks To Watch Right Now

We all love a growing dividend and one of the most popular indices that cover the best dividend growth stocks is the S&P 500 Dividend Aristocrats index.

The index has currently 54 constituents. My goal in this article is to show you the currently cheapest stocks from the Dividend Aristocrats Index with current buy or better ratings.

I know, it�� a little bit easy to trust others work but the high-quality dividend stocks are already discovered. The only thing we must do is to screen the current valuations and market opinions.

Only twelve stocks fulfilled both, a forward P/E below 15 combined with a buy or better rating by brokerage firms. Half of the results have a projected double-digit mid-term earnings growth forecast.

I really like Dividend Aristocrats but because of the highly predictable business model and well known asset class, most of them are no longer cheap. Only eighteen stocks have an expected P/E under 15! That�� only one third of the full database and only around 20 percent of all Aristocrats are recommended to buy.

Top 10 Dow Dividend Stocks For 2016: American Superconductor Corporation(AMSC)

American Superconductor Corporation, together with its subsidiaries, provides wind and power grid products and services primarily in North America, Europe, and the Asia-Pacific. The company?s Wind segment designs, develops, and licenses engineered wind turbine designs to wind turbine manufactures; provides engineering and customer support services; supplies power electronics and software-based control systems to wind turbine manufactures to regulate voltage, control power flows, and maximize wind turbine efficiency; offers consulting services to the wind industry; and provides products that enhance power quality for industrial operations. This segment serves the transmission and distribution, wind power, and manufacturing industries. Its Grid segment manufactures high-temperature superconductor wire and coils; designs and develops superconductor products, such as power cables, fault current limiters, electric motors, generators, and synchronous condensers; manages large-s cale superconductor projects; and provides transmission planning services that identify power grid congestion, poor power quality, and other risks. This segment?s products enable electric utilities and renewable energy project developers to connect, transmit, and distribute power. Its products include D-VAR systems that provide the reactive power needed to stabilize voltage on the grid, and are used to connect wind farms and solar power plants to the power grid; SolarTie Grid Interconnection Systems, which provide the inversion and reactive compensation necessary to connect megawatt-scale solar photovoltaic power plants to the power grid; superconductor wires for various applications, including motors, generators, fault current limiters, and power cables; and power cable systems that are manufactured by third parties, as well as turnkey project management services to electric utilities. American Superconductor Corporation was founded in 1987 and is headquartered in Devens, Massachusetts.

Advisors' Opinion:

• [By Lisa Levin]

  American Superconductor (NASDAQ: AMSC) shares touched a new 52-week low of $1.89. American Superconductor shares have dropped 39.25% over the past 52 weeks, while the S&P 500 index has gained 26.62% in the same period.

• [By Travis Hoium]

  To make matters even more contentious, China has been stealing trade secrets and other intellectual property for years, and that may finally be coming to a head now that it's the second largest economy in the world. Last week, American Superconductor's (NASDAQ: AMSC  ) trade dispute with China was taken to another level when the Department of Justice indicted former AMSC partner Sinovel for stealing trade secrets. All indications are that this should have been an open-and-shut case in China, but the Chinese court system has thrown out the case, or dragged its feet for two years.�

• [By Dan Caplinger]

  On Friday, American Superconductor (NASDAQ: AMSC  ) will release its latest quarterly results. After the loss of its largest customer two years ago, the company has had to make a massive readjustment in its business model, and investors still aren't sure whether it can bounce back from that major setback.

5 Best Cheapest Stocks To Watch Right Now: IDEXX Laboratories Inc (IDXX)

IDEXX Laboratories, Inc., incorporated in 1983, develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The Company operates through three segments: diagnostic and information technology-based products and services for the veterinary market, which it refers to as the Companion Animal Group (CAG), water quality products (Water) and products for livestock and poultry health, which it refer to as Livestock and Poultry Diagnostics (LPD). It also operates two smaller segments that consist of products for milk quality and safety (Dairy) and products for the human point-of-care medical diagnostics market (OPTI Medical). In November 2011, the Company acquired the research and diagnostic laboratory (RADIL) business of the College of Veterinary Medicine from the University of Missouri. In August 2013, IDEXX Laboratories, Inc. announced that it has acquired Madasa do Brasil Ltda.

The Company sells a range of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. Its primary products and services are point-of-care veterinary diagnostic products, consisting of instruments and consumables and rapid assays; veterinary reference laboratory diagnostic and consulting services used by veterinarians; diagnostic and health-monitoring products for livestock and poultry; products that test water for certain microbiological contaminants; practice management systems and services and digital radiography systems used by veterinarians; products that test milk for antibiotic residues and other contaminants, and point-of-care electrolytes and blood gas analyzers used in the human point-of-care medical diagnostics market.

Companion Animal Group

The Company markets a range of in-clinic laboratory analyzers for use in providing reference laboratory quality diagnostic results in companion animal veterinary practices, which it refers ! to as the IDEXX VetLab suite of analyzers. The Company sells two chemistry analyzers, the Catalyst Dx Chemistry Analyzer and the VetTest Chemistry Analyzer, that are used by veterinarians to measure levels of certain enzymes and other substances in blood or urine for monitoring health status and assistance in diagnosing physiologic conditions. Both instruments use consumables manufactured for IDEXX by Ortho-Clinical Diagnostics, Inc. (Ortho), a subsidiary of Johnson & Johnson, based on Ortho�� dry slide technology (Catalyst Dx slides, VetTest slides or slides). In addition, the Catalyst Dx analyzer also uses dry slide electrolyte consumables manufactured by IDEXX at OPTI Medical Systems, one of its wholly owned subsidiaries. Blood tests commonly run on these analyzers include glucose, alkaline phosphatase, alanine aminotransferase (ALT), albumin, creatinine, blood urea nitrogen (BUN), and total protein. Tests are sold individually and in prepackaged panels. Both analyzers also run a urine test called urine protein:creatinine ratio, which assists in the detection of early renal disease.

The Catalyst Dx analyzer is the Company�� chemistry analyzer. The Catalyst Dx analyzer allows a veterinarian to run multiple patient samples simultaneously; to run different sample types, including whole blood, plasma, serum and urine; to perform 28 different chemistry and electrolyte tests; and to automatically calculate other parameters and ratios important to blood chemistry analysis. Its VetLyte Electrolyte Analyzer measures three electrolytes-sodium, potassium and chloride-to aid in evaluating acid-base and electrolyte balances and assessing plasma hydration. Its VetStat Electrolyte and Blood Gas Analyzer measures electrolytes, blood gases, glucose and ionized calcium, and calculates other parameters, such as base excess and anion gap. These measurements aid veterinarians in diagnosing various disease states, evaluating fluid therapy choices and measuring respiratory function. The VetStat analyzer ru! ns single! -use disposable cassettes that contain various configurations of analytes. The VetStat analyzer and its cassettes are manufactured by OPTI Medical Systems.

The Company sells three hematology analyzers that assess the cellular components of blood, including red blood cells, white blood cells and platelets (also called a complete blood count (CBC)). These analyzers include the ProCyte Dx Hematology Analyzer, which uses laser-flow cytometry, optical fluorescence and laminar-flow impedance in its analysis; the LaserCyte Hematology Analyzer, which uses laser-flow cytometry technology in its analysis, and the IDEXX VetAutoread Hematology Analyzer. It also sells the Coag Dx Analyzer, which permits the detection and diagnosis of blood clotting disorders. The ProCyte Dx analyzer provides validated results for five species (canine, feline, equine, bovine and ferret) for up to 24 different blood parameters, providing a more complete picture of each patient�� health.

The SNAPshot Dx analyzer provides quantitative measurements of total thyroxine (T4), cortisol and bile acids to assist in the evaluation of thyroid, adrenal and liver function. The SNAPshot Dx analyzer also reads, interprets and records the results of many IDEXX rapid assay SNAP tests, including its canine SNAP 4Dx test, feline SNAP FIV/FeLV Combo test, canine SNAP cPL test, feline SNAP fPL test, SNAP Feline Triple test and canine SNAP Heartworm RT test. The IDEXX VetLab UA Analyzer provides chemical urinalysis and is validated specifically for veterinary use. The IDEXX VetLab Station (IVLS) connects and integrates the diagnostic information from all the IDEXX VetLab equipment and thus provides reference laboratory information management system capability. It sells the IVLS as an integral component of the Catalyst Dx, LaserCyte and ProCyte Dx analyzers and also as a standalone hardware platform.

The IVLS includes a user interface to input patient information, connect with a practice management system and send i! nformatio! n to run the individual analyzers. IVLS also generates one integrated patient report incorporating all of the lab work generated by the IDEXX VetLab suite; stores, retrieves and analyzes historical patient diagnostics data, including SNAP test results; and sends and receives information from practice management systems, including the IDEXX Cornerstone system, as well as a variety of third-party systems. It sells a range of single-use, handheld test kits under the SNAP name. In addition to its single-use tests, it sells a range of microwell-based test kits under the PetChek name for canine heartworm, FIV and FeLV.

The Company offers commercial reference laboratory diagnostic and consulting services to veterinarians in the United States, Canada, Europe, Australia, Japan, South Africa, China and South Korea and to bioresearch customers in the United States and Europe. The Company provides specialized veterinary consultation, telemedicine and advisory services, including radiology, cardiology, internal medicine and ultrasound consulting. It develops, markets and sells practice management systems, including hardware and software, and services that run certain functions of veterinary clinics, including managing patient electronic health records, scheduling (including boarding and grooming), reminders, billing and inventory management.

The Company markets and sells two digital radiography systems for use in the small animal veterinary hospital: the IDEXX-DR 1417 and the IDEXX I-Vision CR. Its digital radiography systems use IDEXX-PACS and IDEXX EquiView PACS picture archiving and communication system (PACS) software for the viewing, manipulation, management, storage and retrieval of the digital images generated by the digital capture plate. In September 2011, the Company launched IDEXX I-Vision Mobile, an application that allows veterinarians with the IDEXX-DR 1417 and IDEXX I-Vision CR systems, as well as its digital radiography systems, to request, view and send images using an iPa! d or an A! ndroid mobile tablet. This application integrates with its IDEXX-PACS software.

Water

The Company offers a range of products used in the detection and quantification of various microbiological parameters in water. Its principal products are the Colilert, Colilert-18 and Colisure tests, which simultaneously detect the presence of total coliforms and E. coli in water. These organisms are used as indicators of microbial contamination in water. These products utilize indicator-nutrients that produce a change in color or fluorescence when metabolized by target microbes in the sample. Its water tests are used by government laboratories, water utilities and private certified laboratories to test drinking water. The tests also are used in evaluating water used in production processes (for example, in beverage and pharmaceutical applications) and in evaluating bottled water, recreational water, waste water and water from private wells.

Livestock and Poultry Diagnostics

The Company sells diagnostic tests and related instrumentation that are used to detect a range of diseases and to monitor health status in livestock and poultry. Its livestock and poultry diagnostic products are purchased by government and private laboratories that provide testing services to cattle, swine and poultry veterinarians and producers. Its principal products include tests for Bovine Viral Diarrhea Virus (BVDV), Porcine Reproductive and Respiratory Syndrome (PRRS) and Bovine Spongiform Encephalopathy (BSE or mad cow disease). BVDV is a common and contagious viral infection that suppresses the immune system, making the animal susceptible to a host of other infections, impacting beef and dairy production yields as a result. PRRS is a contagious virus causing reproductive problems and respiratory diseases. BSE is a fatal neurodegenerative disease in cattle that causes a spongy degeneration in the brain and spinal cord.

Other

The principal products in the Company�! � Dairy ! business are its SNAP tests used to detect antibiotic drug-residue in milk. Its primary product line for detecting antibiotic residue in milk is SNAP Beta-Lactam, which detects penicillin, amoxicillin, ceftiofur and cephaphirin residues, followed by SNAPduo Beta-Tetra, which detects certain tetracycline antibiotic residues in addition to those detected by the SNAP Beta Lactam test kits. It also sells SNAP tests for the detection of certain other contaminants in milk, such as chemical melamine and Alfatoxin M1.

The Company sells OPTI point-of-care analyzers and related consumables for use in human medical hospitals and clinics to measure electrolytes, blood gases, acid-base balance, glucose, lactate, BUN and ionized calcium, and to calculate other parameters, such as base excess and anion gap. These analyzers are used primarily in emergency rooms, operating rooms, cardiac monitoring areas and other locations where time-critical diagnostic testing is performed within the hospital setting. The OPTI CCA and OPTI Touch Electrolyte and Blood Gas Analyzers run single-use disposable cassettes that contain various configurations of analytes; the OPTI R Analyzer runs reusable cassettes in various analyte configurations; and the OPTI LION Stat Electrolyte Analyzer runs single-use electrolyte cassettes. OPTI Medical Systems also manufactures its VetStat analyzer and provides the electrolyte module and dry slide reagents that make up the electrolyte testing functionality of the Catalyst Dx analyzer.

The Company competes with VCA Antech, Inc., Abaxis, Inc., Butler, Radiometer A/S, Siemens Medical Solutions Diagnostics, Instrumentation Laboratory, Abbott Diagnostics and Roche Diagnostics.

Advisors' Opinion:

• [By Sean Williams]

  Ignore this trend at your own risk
  If you choose to do nothing, then you're playing right into the hands of pharmaceutical giants like Zoetis (NYSE: ZTS  ) , Merck (NYSE: MRK  ) , and IDEXX Laboratories (NASDAQ: IDXX  ) , which are counting on your indifference to drive their profits.

• [By Tim Brugger]

  After 10 years on the board of IDEXX Laboratories (NASDAQ: IDXX  ) , including serving on its audit and compensation committees, Brian McKeon has been named IDEXX's new executive vice president and CFO, the company announced today. McKeon's appointment as CFO becomes effective Jan. 1, though he has resigned from the IDEXX board as of Oct. 11, the company said.

• [By CanadianValue]

  Idexx (IDXX) performed well in 2011, generating solid revenue growth and high-teens earnings growth thanks to a slight recovery in the veterinary end market, the ramp up of its new ProCyte hematology instrument, continued share gains in reference laboratories and one-time gains from production animal disease eradication programs in Europe. While we continue to like the company�� prospects and are impressed with its execution in a still sluggish market for animal healthcare, we trimmed our position in 2011 at prices we found attractive given our expectations for the business.

5 Best Cheapest Stocks To Watch Right Now: Corrections Corporation of America (CXW)

Corrections Corporation of America (CCA) incorporated on September 24, 1998, is a real estate investment trust. The Company is the owner of privatized correctional and detention facilities and prison operators in the United States. As of December 31, 2012, the Company operated 67 correctional and detention facilities, including 47 facilities that the Company own, with a total design capacity of approximately 92,500 beds in 20 states and the District of Columbia. Beginning of January 1, 2013, the Company has provided correctional services and conducted other operations through TRSs. A TRS is a subsidiary of a REIT that is subject to applicable corporate income tax and certain qualification requirements. In January 2012, the Company closed the operations of the 1,172-bed Delta Correctional Facility in Greenwood, Mississippi. In January 2013, the Company announced that it has completed an internal reorganization of its business operations.

The Company specializes in owning, operating, and managing prisons and other correctional facilities and providing inmate residential and prisoner transportation services for governmental agencies. In addition to providing the fundamental residential services relating to inmates, its facilities offer a variety of rehabilitation and educational programs, including basic education, religious services, life skills and employment training and substance abuse treatment. These services are intended to help reduce recidivism and to prepare inmates for their re entry into society upon their release. The Company also provides health care (including medical, dental, and mental health services), food services, and work and recreational programs.

The Company�� customers consist of federal, state and local correctional and detention authorities. During the year ended December 31, 2012, federal correctional and detention authorities represented 43% of its total revenue. Federal correctional and detention authorities primarily consist of the Federal Burea! u of Prisons (BOP), the United States Marshals Service (USMS), and the United States Immigration and Customs Enforcement (ICE). Its management services contracts typically have terms of three to five years and contain multiple renewal options. Its facility contracts also contain clauses that allow the government agency to terminate the contract at any time without cause, and its contracts are generally subject to annual or bi-annual legislative appropriations of funds.

The Company is compensated for providing prison bed capacity and correctional services at an inmate per diem rate based upon actual or minimum guaranteed occupancy levels. Occupancy rates for a particular facility are typically low when opened or immediately following an expansion. However, beyond the start-up period, which typically ranges from 90 to 180 days, the occupancy rate tends to stabilize. During 2012, the average compensated occupancy of its facilities, based on rated capacity, was 88.2% for all of the facilities it owned or managed, exclusive of facilities where operations have been discontinued.

The Company provides a variety of rehabilitative and educational programs at its facilities. Inmates at facilities the Company manage may receive basic education through academic programs designed to improve literacy levels and the opportunity to acquire GED certificates. The Company also offers vocational training to inmates who lack marketable job skills. Its craft vocational training programs are accredited by the National Center for Construction Education and Research. This foundation provides training curriculum and establishes industry standards for over 4,000 construction and trade organizations in the United States and several foreign countries. In addition, the Company offers life skills transition-planning programs that provide inmates with job search skills, health education, financial responsibility training, parenting training, and other skills associated with becoming productive citizens.

! As of December 31, 2012, the Company provides transportation services to governmental agencies through its wholly owned TRS, TransCor America, LLC, or TransCor. CCA owns 49 correctional and detention facilities in 15 states and the District of Columbia, two of which it leases to third-party operators. The Company also owns two corporate office buildings. Additionally, it manages 20 correctional and detention facilities owned by government agencies. Owned and managed facilities include facilities placed into service that the Company owned and managed. Managed-only facilities include facilities owned by a third party and managed by the Company.

The Company competes with The GEO Group, Inc. and Management and Training Corporation.

Advisors' Opinion:

• [By Ben Levisohn]

  Prison REIT Corrections Corp of America (CXW) yields 6.2% and trades at 24.9 times earnings, while�Geo Group (GEO) yields 6.4% on a P-E ratio of 20.8 times.

5 Best Cheapest Stocks To Watch Right Now: Brazil Gold Corp (BRZG)

Brazil Gold Corp. incorporated on June 17, 2004, is engaged in reviewing mineral exploration. The Company has a Letter of Intent with Mineracao Rio De Padreas Ltda to acquire up to 100% of Mineracao�� interests in the Luziania Gold Project located in Goias State, Brazil. The Luziania Gold Project (LGP) is located about 50 kilometers southwest of Brasilia and 10 kilometers from the City of Luziania. LGP carries mining permits, environmental impact studies and ore recovery analyses. Effective July 30, 2013, Brazil Gold Corp acquired a 20% interest in FAL Minerals LLC, a gold mining company.

The Company is focused on reviewing exploration and other opportunities with the objective of bringing revenue to the Company. As of June 30, 2011, the Company was focused on evaluating possible new ventures and acquisitions. As of June 30, 2011, the Company had not generated any revenues from its operations.

Advisors' Opinion:

• [By Peter Graham]

  Small cap mining stocks Brazil Gold Corp (OTCMKTS: BRZG) and Trulan Resources (OTCMKTS: TRLR) were either active on the charts last week (in the case of the former) or recently the subject of paid promotions (in the case of the latter). However, mining is not exactly an easy business for a small and usually undercapitalized small cap mining stock given the amount it can cost to get a mine up and running. On the other hand, they could always be sitting on the next mother lode just waiting to come out of the ground. With that in mind, here is a quick reality check about these two small cap mining stocks: